Published in JAMA on December 16, 1988
Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes | NCT00577590
Expression of Angiogenic Factors in Myocardial Tissue | NCT01414621
Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. Am J Manag Care (2008) 2.80
Sex differences in mortality following acute coronary syndromes. JAMA (2009) 2.17
Insulin infusion in diabetic patients with acute myocardial infarction. BMJ (1996) 2.02
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med (2007) 1.90
Nuclear receptors PPARbeta/delta and PPARalpha direct distinct metabolic regulatory programs in the mouse heart. J Clin Invest (2007) 1.88
Cardiovascular safety of sitagliptin in patients with type 2 diabetes mellitus: a pooled analysis. Cardiovasc Diabetol (2013) 1.17
Factors determining case fatality in myocardial infarction "who dies in a heart attack"? Br Heart J (1995) 1.15
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart (2004) 1.14
Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta (2011) 1.12
Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm (2011) 1.12
Protective ischaemia in patients: preconditioning and postconditioning. Cardiovasc Res (2009) 1.10
Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction. J Mol Cell Cardiol (2009) 1.09
Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes. Diabetes Metab Syndr Obes (2011) 1.05
Preconditioning the diabetic human myocardium. J Cell Mol Med (2009) 1.01
The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities. Dis Model Mech (2014) 0.99
Causes and characteristics of diabetic cardiomyopathy. Rev Diabet Stud (2006) 0.99
Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure. Eur J Heart Fail (2011) 0.99
Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart. Heart (2003) 0.96
Cardiomyocyte health: adapting to metabolic changes through autophagy. Trends Endocrinol Metab (2013) 0.92
The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ Heart Fail (2011) 0.91
Age and sex differences in hospitalizations associated with diabetes. J Womens Health (Larchmt) (2010) 0.90
Crucial role of calcium-sensing receptor activation in cardiac injury of diabetic rats. PLoS One (2013) 0.90
Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.89
Relationship between glycosylated hemoglobin assessment and glucose therapy intensification in patients with diabetes hospitalized for acute myocardial infarction. Diabetes Care (2012) 0.89
Management of diabetic nephropathy. J R Soc Med (2001) 0.87
Screening for coronary artery disease in patients with type 2 diabetes mellitus: An evidence-based review. Indian J Endocrinol Metab (2012) 0.87
Autonomic neuropathy and survival in diabetes mellitus: effects of pancreas transplantation. Diabetologia (1991) 0.85
Diabetic cardiovascular disease: getting to the heart of the matter. J Cardiovasc Transl Res (2012) 0.85
Predictor of poor coronary collaterals in chronic kidney disease population with significant coronary artery disease. BMC Nephrol (2012) 0.84
Evaluation of the effect of systolic blood pressure and pulse pressure on cognitive function: the Women's Health and Aging Study II. PLoS One (2011) 0.84
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol (2015) 0.83
Obesity-related cardiorenal disease: the benefits of bariatric surgery. Nat Rev Nephrol (2013) 0.83
Impact of the joint association between sex, age and diabetes on long-term mortality after acute myocardial infarction. BMC Public Health (2015) 0.79
Impact of hypoglycemic agents on myocardial ischemic preconditioning. World J Diabetes (2014) 0.79
Loss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signaling. PLoS One (2014) 0.79
Characteristics of high-density lipoprotein subclasses distribution for subjects with desirable total cholesterol levels. Lipids Health Dis (2011) 0.78
Downregulation in GATA4 and Downstream Structural and Contractile Genes in the db/db Mouse Heart. ISRN Endocrinol (2012) 0.78
Diabetes and sepsis outcomes--it is not all bad news. Crit Care (2009) 0.77
Mortality after myocardial infarction in patients with diabetes mellitus. Heart (2007) 0.77
Cardiovascular disease and diabetes: modifying risk factors other than glucose control. Ochsner J (2001) 0.77
ApoA-1 in diabetes: damaged goods. Diabetes (2010) 0.77
The role of renin-angiotensin agents in altering the natural history of type 2 diabetes mellitus. Curr Cardiol Rep (2010) 0.77
Role of cardiac MRI in diabetes. Curr Cardiol Rep (2014) 0.77
Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Sleep Breath (2015) 0.76
Whole-Body MR Imaging Including Angiography: Predicting Recurrent Events in Diabetics. Eur Radiol (2015) 0.76
Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience. Nutr Metab Cardiovasc Dis (2010) 0.76
Does control of diabetes prevent vascular complications? JAMA (1989) 0.75
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria. Ther Clin Risk Manag (2008) 0.75
Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adults. World J Diabetes (2016) 0.75
Paradoxical lower postmyocardial infarction mortality among veteran women--does a sex bias exist in the Veterans Affairs medical system? Can J Cardiol (2008) 0.75
Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications. J Diabetes Investig (2012) 0.75
Effects of metabolic and myocardial microcirculatory abnormalities on the pathogenesis of cardiac autonomic neuropathy in type 2 diabetes mellitus: A prospective study in Japanese patients. Curr Ther Res Clin Exp (2005) 0.75
Stereological study of the diabetic heart of male rats. Lab Anim Res (2013) 0.75
Lipid lowering in patients with diabetes mellitus: what coronary heart disease risk threshold should be used? Heart (2002) 0.75
Race-Sex Differences in Statin Use and Low-Density Lipoprotein Cholesterol Control Among People With Diabetes Mellitus in the Reasons for Geographic and Racial Differences in Stroke Study. J Am Heart Assoc (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol (1979) 18.84
Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med (1990) 17.52
CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol (1988) 15.40
High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med (1977) 15.39
The natural history of congestive heart failure: the Framingham study. N Engl J Med (1971) 13.94
Diabetes and cardiovascular disease. The Framingham study. JAMA (1979) 11.95
An updated coronary risk profile. A statement for health professionals. Circulation (1991) 11.71
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med (1982) 8.62
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med (1987) 8.09
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA (1986) 7.23
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. JAMA (1970) 6.42
STATISTICAL METHODS AND CONTROL IN BACTERIOLOGY. Bacteriol Rev (1943) 6.32
The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med (1999) 6.22
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke (1994) 5.83
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
BIOLOGICAL DETERMINATION OF VITAMIN B1 (THIAMIN) IN RHIZOBIUM TRIFOLII. Science (1938) 5.59
Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes (1974) 5.55
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology (1978) 5.37
Diabetes and cardiovascular risk factors: the Framingham study. Circulation (1979) 5.32
Mechanism of Biological Nitrogen Fixation: VI. Inhibition of Azotobacter by Hydrogen. Proc Natl Acad Sci U S A (1941) 5.23
Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA (1993) 5.21
Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol (1974) 5.11
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
A general cardiovascular risk profile: the Framingham Study. Am J Cardiol (1976) 5.10
Natural history of angina pectoris in the Framingham study. Prognosis and survival. Am J Cardiol (1972) 5.05
Formation of the nitrogen-fixing enzyme system in Azotobacter vinelandii. Can J Microbiol (1968) 5.05
Incidence and prognosis of unrecognized myocardial infarction. An update on the Framingham study. N Engl J Med (1984) 5.02
Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med (1979) 4.94
Systolic versus diastolic blood pressure and risk of coronary heart disease. The Framingham study. Am J Cardiol (1971) 4.90
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Some health benefits of physical activity. The Framingham Study. Arch Intern Med (1979) 4.63
Mechanism of biological nitrogen fixation: Molecular H(2) and the pN(2) function of azotobacter. Biochem J (1941) 4.45
Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med (1995) 4.36
The epidemiology of gallbladder disease: observations in the Framingham Study. J Chronic Dis (1966) 4.15
Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J (1987) 4.12
Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study. Ann Intern Med (1970) 4.11
The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med (1993) 4.04
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis (2000) 3.81
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr (2001) 3.80
Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med (1998) 3.79
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study. JAMA (1996) 3.68
Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J (2000) 3.61
Parental transmission of type 2 diabetes: the Framingham Offspring Study. Diabetes (2000) 3.60
Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA (1987) 3.59
Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med (1976) 3.50
The Relationship Between Photosynthesis and Nitrogen Fixation. Proc Natl Acad Sci U S A (1952) 3.47
Psychological predictors of hypertension in the Framingham Study. Is there tension in hypertension? JAMA (1993) 3.42
NITROGEN FIXATION BY PHOTOSYNTHETIC BACTERIA. J Bacteriol (1949) 3.33
Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation (1990) 3.29
Absence of centrioles in the first and second meiotic spindles of mouse oocytes. J Cell Sci (1972) 3.24
INFLUENCE OF POTASSIUM NITRATE ON NODULE FORMATION AND NITROGEN FIXATION BY CLOVER. Plant Physiol (1932) 3.23
Premature mortality from coronary heart disease. The Framingham study. JAMA (1971) 3.15
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Risk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis Study. J Bone Miner Res (2000) 3.09
Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr (1994) 3.08
The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med (1967) 3.05
Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med (1987) 3.00
ENZYME LOCALIZATION IN Azotobacter Vinelandii. Proc Natl Acad Sci U S A (1955) 2.97
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA (1981) 2.93
Improved cloning vectors and transformation procedure for Lactococcus lactis. J Appl Bacteriol (1993) 2.91
Role of blood pressure in the development of congestive heart failure. The Framingham study. N Engl J Med (1972) 2.91
Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med (1969) 2.88
The relationship of psychosocial factors to coronary heart disease in the Framingham Study. III. Eight-year incidence of coronary heart disease. Am J Epidemiol (1980) 2.86
Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med (1987) 2.82
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. Lancet (1974) 2.81
Labile hypertension: a faulty concept? The Framingham study. Circulation (1980) 2.76
Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A (1968) 2.74
Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation (1975) 2.74
Hearing in the elderly: the Framingham cohort, 1983-1985. Part I. Basic audiometric test results. Ear Hear (1990) 2.71
Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study. N Engl J Med (1985) 2.71
Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke (2001) 2.71
Clustering of metabolic factors and coronary heart disease. Arch Intern Med (1999) 2.69
Ammonia as an Intermediate in Nitrogen Fixation by Azotobacter. J Bacteriol (1946) 2.68
Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA (1988) 2.68
Menopause and coronary heart disease. The Framingham Study. Ann Intern Med (1978) 2.62